Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?

Por Melina C den Haan, Vanessa-Leigh van Zuylen, Niek J Pluijmert, Cindy I Schutte, Willem E Fibbe, Martin J Schalij, Helene Roelofs, Douwe E Atsma
Publicado em 2016-01-01

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?

Por Guido Moll, Annika Hult, Lena von Bahr, Jessica J Alm, Nina Heldring, Osama A Hamad, Lillemor Stenbeck-Funke, Stella Larsson, Yuji Teramura, Helene Roelofs, Bo Nilsson, Willem E Fibbe, Martin L Olsson, Katarina Le Blanc
Publicado em 2014-01-01